Clinical trial
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA)…
NCT00352898 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00352898 |
|---|---|
| Title | Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ |
| Official title | Comparative Study Evaluating the Immunogenicity & Safety of MeMuRu-OKA Vaccine & Measles-mumps-rubella Vaccine (Priorix™) Co-administered With Varicella Vaccine (Varilrix™) in Children Primed With Both Measles-mumps-rubella & Varicella Vaccines |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mumps, Rubella, Measles, Varicella |
| Intervention type | Biological |
| Interventions | MeMuRu-OKA (study vac), MMR, Varicella vacc (control) |
| Enrollment | 400 |
| Start date | Apr 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jul 17, 2006 |
| Last update posted | Oct 7, 2016 |
| Countries | Canada, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: